| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 200.69M | 161.69M | 181.09M | 173.70M | 154.82M | 114.09M |
| Gross Profit | 62.30M | 50.35M | 54.74M | 56.94M | 54.23M | 41.34M |
| EBITDA | -135.00K | 4.13M | -29.02M | 16.40M | -34.64M | 8.16M |
| Net Income | -10.55M | -6.62M | -39.98M | 1.82M | -51.00M | -4.54M |
Balance Sheet | ||||||
| Total Assets | 106.82M | 106.82M | 117.10M | 173.45M | 191.82M | 223.59M |
| Cash, Cash Equivalents and Short-Term Investments | 24.08M | 24.08M | 18.23M | 9.88M | 5.77M | 25.10M |
| Total Debt | 11.72M | 11.72M | 15.60M | 25.17M | 24.49M | 29.17M |
| Total Liabilities | 38.19M | 38.19M | 41.91M | 53.22M | 63.72M | 52.51M |
| Stockholders Equity | 66.88M | 66.88M | 73.49M | 118.20M | 126.18M | 169.31M |
Cash Flow | ||||||
| Free Cash Flow | 9.92M | 9.92M | 5.89M | 5.47M | -4.86M | -4.34M |
| Operating Cash Flow | 10.65M | 10.65M | 9.30M | 9.38M | 2.12M | 7.61M |
| Investing Cash Flow | -697.00K | -697.00K | 674.00K | -3.84M | -6.93M | -11.84M |
| Financing Cash Flow | -3.71M | -3.71M | -1.04M | -802.00K | -14.97M | 4.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$91.20M | 9.05 | 9.25% | 2.19% | 27.91% | 18.87% | |
65 Neutral | HK$9.68B | 51.47 | 5.07% | 1.46% | 0.33% | -44.28% | |
65 Neutral | HK$7.47B | 21.29 | 6.77% | 2.82% | 29.81% | 10.40% | |
52 Neutral | HK$86.83M | -13.14 | -11.91% | ― | -4.50% | 75.98% | |
52 Neutral | HK$910.61M | -6.13 | -305.54% | ― | -35.02% | -64.05% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Wanjia Group Holdings Limited has announced that its Board of Directors will hold a meeting on November 19, 2025, to discuss several key issues. The meeting will focus on approving the unaudited interim results for the six months ending September 30, 2025, considering the payment of an interim dividend, and potentially closing the register of members. This meeting is significant as it will determine the financial direction of the company and could impact shareholder returns and market perception.
Wanjia Group Holdings Ltd. announced that its subsidiary, Wuhua Yongke Kidney Hemodialysis Company, received a notice from Wuhua County Medical Insurance Management Centre due to non-compliance with prescription practices. This has led to a temporary suspension of their Insurance Service Agreement for 61 days. The company is implementing rectification measures to address the issue and ensure compliance, while redirecting patients to other centers. The suspension is not expected to have a material adverse impact on the company’s overall financial position or operations.
Wanjia Group Holdings Limited announced that all resolutions proposed at their Annual General Meeting on September 5, 2025, were unanimously approved by shareholders. The resolutions included adopting the financial statements, re-electing directors, authorizing director remuneration, re-appointing auditors, and granting mandates for issuing and repurchasing shares. This unanimous approval reflects strong shareholder support and positions the company for continued strategic initiatives and operational stability.